Caffeine metabolism rate influences coffee perception, preferences and intake

Food Quality and Preference

Volumn 53, Issue , 2016, Pages 97-104

  Masi, Camilla ^a   Dinnella, Caterina ^a   Pirastu, Nicola ^b,c   Prescott, John ^a,d   Monteleone, Erminio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d TasteMatters Research and Consulting   (Australia)

Author keywords

Bitterness responsiveness; Coffee consumption; Sugar use

Indexed keywords

EID: 84974667593     PISSN: 09503293     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodqual.2016.06.002     Document Type: Article

References (79)

1. Aklillu E., Carrillo J.A., Makonnen E., Hellman K., Pitarque M., Bertilsson L., Ingelman-Sundberg M. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: Characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Molecular Pharmacology 2003, 64:659-669.
2. Andueza S., Paz De Peña M., Cid C. Chemical and sensorial characteristics of espresso coffee as affected by grinding and torrefacto roast. Journal of Agricultural and Food Chemistry 2003, 51(24):7034-7039.
3. Arnaud M. Metabolism of caffeine and other components of coffee. Caffeine, coffee, and health 1993, 43-96. Raven Press, New York. S. Garattini (Ed.).
4. Bartoshuk L., Duffy V., Fast K., Green B., Prutkin J., Snyder D. Labeled scales (e.g., category, Likert, VAS) and invalid across-group comparisons: What we have learned from genetic variation in taste. Food Quality and Preference 2002, 14(2):125-138.
5. Bech B.H., Autrup H., Nohr E.A., Henriksen T.B., Olsen J. Stillbirth and slow metabolizers of caffeine: Comparison by genotypes. International Journal of Epidemiology 2006, 35(4):948-953.
6. Berthou F., Goasduff T., Dréano Y., Ménez J. Caffeine increases its own metabolism through cytochrome P4501A induction in rats. Life Sciences 1995, 57(6):541-549.
7. Brice C., Smith A.P. Caffeine levels in saliva: Associations with psychosocial factors and behavioural effects. Human Psychopharmacology 2001, 16(7):507-521.
8. Campbell M., Grant D., Inaba T., Kalow W. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome (s) P-450 in human liver microsomes. Drug Metabolism and Disposition 1987, 15(2):237-249.
9. Chevalier D., Cauffiez C., Allorge D., Lo Guidice J., Lhermitte M., Lafitte J., Broly F. Five novel natural allelic variants-951A> C, 1042G> A (D348N), 1156A> T (I386F), 1217G> A (C406Y) and 1291C> T (C431Y)-of the human CYP1A2 gene in a French Caucasian population. Human Mutation 2001, 17(4):355-356.
10. Christensen M., Tybring G., Mihara K., Yasui-Furokori N., Carrillo J.A., Ramos S.I., Bertilsson I. Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the met- abolism of both caffeine (cytochrome P450 1A2) and omeprazole (cytochrome P4502C19). Clinical Pharmacology and Therapeutics 2002, 71:141-152.
11. Cook D.G., Peacock J.L., Feyerabend C., Carey I.M., Jarvis M.J., Anderson H.R., Bland J.M. Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: Prospective population based study. BMJ 1996, 313(7069):1358-1362.
12. Cornelis M., Byrne E, Esko T., Nall M., Ganna A., Paynter N., Al E. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Molecular Psychiatry 2015, 1-10.
13. Cornelis M.C., El-Sohemy A., Campos H. Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. The American Journal of Clinical Nutrition 2007, 86(1):240-244.
14. Davino C., Romano R., Næs T. The use of quantile regression in consumer studies. Food Quality and Preference 2015, 40:230-239.
15. Dinehart M., Hayes J., Bartoshuk L., Lanier S., Duffy V. Bitter taste markers explain variability in vegetable sweetness, bitterness, and intake. Physiology & Behavior 2006, 87(2):304-313.
16. Dinnella C., Recchia A., Fia G., Bertuccioli M., Monteleone E. Saliva Characteristics and Individual Sensitivity to Phenolic Astringent Stimuli. Chemical Senses 2009, 34(4):295-304.
17. Dinnella C., Recchia A., Tuorila H., Monteleone E. Individual astringency responsiveness affects the acceptance of phenol-rich foods. Appetite 2011, 56(3):633-642.
18. Djordjevic N., Ghotbi R., Bertilsson L., Jankovic S., Aklillu E. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. European Journal of Clinical Pharmacology 2008, 64(4):381-385.
19. Duffy V., Peterson J., Bartoshuk L. Associations between taste genetics, oral sensation and alcohol intake. Physiology and Behavior 2004, 82(2-3):435-445.
20. Faber M.S., Jetter A., Fuhr U. Assessment of CYP1A2 activity in clinical practice: Why, how, and when?. Basic & Clinical Pharmacology & Toxicology 2005, 97(3):125-134.
21. Fleming E., Ziegler G., Hayes J. Salivary protein levels as a predictor of perceived astringency in model systems and solid foods. Physiology and Behavior 2016, 163:56-63.
22. Frank O., Blumberg S., Kunert C., Zehentbauer G., Hofmann T. Structure determination and sensory analysis of bitter-tasting 4-vinylcatechol oligomers and their identification in roasted coffee by means of LC-MS/MS. Journal of Agricultural and Food Chemistry 2007, 55(5):1945-1954.
23. Frank O., Zehentbauer G., Hofmann T. Bioresponse-guided decomposition of roast coffee beverage and identification of key bitter taste compounds. European Food Research and Technology 2006, 222(5-6):492-508.
24. Fuhr U., Anders E., Mahr G., Sorgel F., Staib A. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro. Antimicrobical Agents and Chemotherapy 1992, 36:942-948.
25. Gardner M.J., Tornatore K., Jusko W., Kanarkowski R. Effects of tobacco smoking and oral contraceptive use on theophylline disposition. British Journal of Clinical Pharmacology 1983, 16:271-280.
26. Grant D., Tang B., Kalow W. Variability in caffeine metabolism. Clinical Pharmacology and Therapeutics 1983, 33(5):591-602.
27. Green B., Shaffer G., Gilmore M. Derivation and evaluation of a semantic scale of oral sensation magnitude with apparent ratio properties. Chemical Senses 1993, 18(6):683-702.
28. Grosso L.M., Bracken M.B. Caffeine metabolism, genetics, and perinatal outcomes: A review of exposure assessment considerations during pregnancy. Annals of Epidemiology 2005, 15(6):460-466.
29. Gu L., Gonzalez F.J., Kalow W., Tang B. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics and Genomics 1992, 2(2):73-77.
30. Han X.-M., Ou-Yang D.-S., Lu P.-X., Jiang C.-H., Shu Y., Chen X.-P., Zhou H.-H. Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. Pharmacogenetics and Genomics 2001, 11(5):429-435.
31. Haskell C.F., Kennedy D.O., Wesnes K.A., Scholey A.B. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl) 2005, 179(4):813-825.
32. Hayes J., Duffy V. Revisiting sugar-fat mixtures: Sweetness and creaminess vary with phenotypic markers of oral sensation. Chemical Senses 2007, 32(3):225-236.
33. Hayes J., Wallace M., Knopik V., Herbstman D., Bartoshuk L., Duffy V. Allelic variation in TAS2R bitter receptor genes associates with variation in sensations from and ingestive behaviors toward common bitter beverages in adults. Chemical Senses 2011, 36(3):311-319.
34. Hinds T., West W., Knight E., Harland B. The effect of caffeine on pregnancy outcome variables. Nutrition Reviews 1996, 54:203-207.
35. Huntley E.D., Juliano L.M. Caffeine Expectancy Questionnaire (CaffEQ): Construction, psychometric properties, and associations with caffeine use, caffeine dependence, and other related variables. Psychological Assessment 2012, 24(3):592-607.
36. Kall M.A., Clausen J. Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man. Human Experimental in Toxicology 1995, 14:801-807.
37. Keast R., Roper J. A complex relationship among chemical concentration, detection threshold, and suprathreshold intensity of bitter compounds. Chemical Senses 2007, 32(3):245-253.
38. Le Marchand L., Franke A., Custer L., Wilkens L., Cooney R. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: Inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics 1997, 7:11-19.
39. Leclercq C., Arcella D., Piccinelli R., Sette S., Le Donne C., Turrini A. The Italian National Food Consumption Survey INRAN-SCAI 2005-06: Main results in terms of food consumption. Public Health Nutrition 2009, 12(12):2504-2532.
40. Lelo A., Birkett D., Robson R., Miners J. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. British Journal of Clinical Pharmacology 1986, 22:177-182.
41. Lieberman H., Tharion W.J., Shukitt-Hale B., Speckman K.L., Tulley R. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land. Psychopharmacology (Berl) 2002, 164(3):250-261.
42. Lindinger C., Labbe D., Pollien P., Rytz A., Juillerat M., Yeretzian C., Blank I. When machine tastes coffee: Instrumental approach to predict the sensory profile of espresso coffee. Analytical Chemistry 2008, 80(5):1574-1581.
43. Ly A., Drewnowski A. PROP (6-n-Propylthiouracil) tasting and sensory responses to caffeine, sucrose, neohesperidin dihydrochalcone and chocolate. Chemical Senses 2001, 26(1):41-47.
44. Maeztu L., Sanz C., Andueza S., De Peña M.P., Bello J., Cid C. Characterization of espresso coffee aroma by static headspace GC-MS and sensory flavor profile. Journal of Agricultural and Food Chemistry 2001, 49(11):5437-5444.
45. Masi C., Dinnella C., Monteleone E., Prescott J. The impact of individual variations in taste sensitivity on coffee perceptions and preferences. Physiology & Behavior 2015, 138:219-226.
46. Mastaneh S., Hayes J., Duffy V. Masking vegetable bitterness to improve palatability depends on vegetable type and taste phenotype. Chemosensory Perception 2013, 6(1):8-19.
47. McDonagh J., Nathan V., Bonavia I., Moyle G., Tanner A. Caffeine clearance by enzyme multiplied immunoassay technique: A simple, inexpensive, and useful indicator of liver function. Gut 1991, 32:681-684.
48. Methven L., Langreney E., Prescott J. Changes in liking for a no added salt soup as a function of exposure. Food Quality and Preference 2012, 26(2):135-140.
49. Miceli J.N., Aravind M.K., Ferrell W.J. Analysis of caffeine: Comparison of the Manual Enzyme Multiplied Immunoassay (EMIT), automated EMIT, and high-performance liquid chromatography procedures. Therapeutic Drug Monitoring 1984, 6(3):344-347.
50. Miners J., Birkett D. The use of caffeine as a metabolic probe for human drug metabolizing enzymes. General Pharmacology 1996, 27:245-249.
51. Nakajima M., Yokoi T., Mizutani M., Kinoshita M., Funayama M., Kamataki T. Genetic polymorphism in the 50-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans. The Journal of Biochemestry 1999, 125:803-808.
52. Nebesny E., Budryn G. Evaluation of sensory attributes of coffee brews from robusta coffee roasted under different conditions. European Food Research and Technology 2006, 224(2):159-165.
53. Nehlig A., Daval J., Debry G. Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Research Reviews 1992, 17(2):139-170.
54. Newton R., Broughton L.J., Lind M.J., Morrison P.J., Rogers H.J., Bradbrook I.D. Plasma and salivary pharmacokinetics of caffeine in man. European Journal of Clinical Pharmacology 1981, 21(1):45-52.
55. Nousbaum J.B., Berthou F., Carlhant D., Riche C., Robaszkie-wicz M., Gouerou H. Four-week treatment with omeprazole in- creases the metabolism of caffeine. American Journal of Gastroenterology 1994, 89:371-375.
56. Parker A.C., Pritchard P., Preston T., Choonara I. Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test. British Journal of Clinical Pharmacology 1998, 45:176-178.
57. Perera V., Gross A.S., McLachlan A.J. Influence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestry. Clinical Pharmacology and Therapeutics 2012, 92(4):511-519.
58. Perera V., Gross A.S., Xu H., McLachlan A.J. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics. The Journal of Pharmacy and Pharmacology 2011, 63(9):1161-1168.
59. Pirastu N., Kooyman M., Traglia M., Robino A., Willems S.M., Pistis G., Gasparini P. Association analysis of bitter receptor genes in five isolated populations identifies a significant correlation between TAS2R43 variants and coffee liking. PLoS ONE 2014, 9(3):e92065.
60. Prescott J. Effects of added glutamate on liking for novel food flavors. Appetite 2004, 42(2):143-150.
61. Prescott J., Ripandelli N., Wakeling I. Intensity of tastes in binary mixtures in PROP non-tasters, medium-tasters and super-tasters. Chemical Senses 2001, 26:993-1003.
62. Prescott J., Soo J., Campbell H., Roberts C. Responses of PROP taster groups to variations in sensory qualities within foods and beverages. Physiology & Behavior 2004, 82(2-3):459-469.
63. Rozin P., Zellner D. The role of pavlovian conditioning in the acquisition of food likes and dislikes. Annals of the New York Academy of Sciences 1985, 443(1):189-202.
64. Sachse C., Bhambra U., Smith G., Lightfoot T., Barrett J., Scollay J., The Colorectal Cancer Study Group Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: Allele frequencies, linkage disequilibrium and influence on caffeine metabolism. British Journal of Clinical Pharmacology Pharmacology 2003, 55:68-76.
65. Sachse C., Brockmoller J., Bauer S., Roots I. Functional significance of a C to A polymorphismin intron 1 of the cytochrome P4501A2 (CYP1A2) gene tested with caffeine. British Journal of Clinical Pharmacology 1999, 47:445-449.
66. Santos R., Cotta K., Jiang S., Lima D. Does CYP1A2 genotype influence coffee consumption. Austin Journal of Pharmacology and Therapeutics 2015, 3(1):1065.
67. Schenker S., Heinemann C., Huber M., Pompizzi R., Perren R., Fischer F. Impact of roasting conditions on the formation of aroma compounds in coffee beans. Food Engineering and Physical Properties 2002, 67(1):60-66.
68. Signorello L., Nordmark A., Granath F., Blot W., McLaughlin J., Annerén G., Cnattingius S. Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses. Obstetrics and Gynecology 2001, 98:1059-1066.
69. Simon T., Becquemont L., Hamon B., Nouyrigat E., Chodjania Y., Poirier J.M., Jaillon P. Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers. British Journal of Clinical Pharmacology 2001, 52(5):601-604.
70. Steiner J.E., Glaser D., Hawilo M.E., Berridge K.C. Comparative expression of hedonic impact: Affective reactions to taste by human infants and other primates. Neuroscience and Biobehavioral Reviews 2001, 25(1):53-74.
71. Tantcheva-Poòr I., Zaigler M., Rietbrock S., Fuhr U. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 1999, 9:131-144.
72. Tassaneeyakul W., Birkett D., McManus M., Tassaneeyakul W., Veronese M., Andersson T., et al. Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms. Biochemical Pharmacology 1994, 47(10):1767-1776.
73. Tinley E., Yeomans M., Durlach P. Caffeine reinforces flavour preference in caffeine-dependent, but not long-term withdrawn, caffeine consumers. Psychopharmacology (Berl) 2003, 166(4):416-423.
74. Vistisen K., Loft S., Poulsen H. Cytochrome P450 IA2 activ- ity in man measured by caffeine metabolism: Effect of smoking, broccoli and exercise. Advances in Experimental Medicine and Biology 1991, 283:407-411.
75. Yeomans M. Understanding individual differences in acquired flavour liking in humans. Chemosensory Perception 2010, 3(1):34-41.
76. Yeomans M., Jackson A., Lee M., Nesic J., Durlach P. Expression of flavour preferences conditioned by caffeine is dependent on caffeine deprivation state. Psychopharmacology (Berl) 2000, 150(2):208-215.
77. Yeomans M., Mobini S. Hunger alters the expression of acquired hedonic but not sensory qualities of food-paired odors in humans. Journal of Experimental Psychology: Animal Behavior Processes 2006, 32(4):460-466.
78. Zaigler M., Tantcheva-Poòr I., Fuhr U. Problems and perspectives of phenotyping for drug-metabolizing enzymes in man. International Journal of Clinical Pharmacology and Terapeutics 2000, 38:1-9.
79. Zysset T., Wahlländer A., Preisig R. Evaluation of caffeine plasma levels by an automated enzyme immunoassay (EMIT) in comparison with a high-performance liquid chromatographic method. Therapeutic Drug Monitoring 1984, 6(3):348-354.